Waypoint Bio
PrivateLast Round
Series A
May 27, 2026
Total Funding Raised
$34.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Waypoint Bio operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in May 2026.
Waypoint Bio is a biotechnology company that develops next-generation cell therapies for solid tumors using a proprietary spatial pooled screening platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Waypoint Bio Comparables
Compare Waypoint Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tahoe Therapeutics | 83% | |
| Insitro | 80% | |
| Gordian Biotechnology | 78% |
For institutional investors. Book with your work email.
Waypoint Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2026 | ||||
| Seed | Jun 28, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Waypoint Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Time BioVentures | Series A |
| Mitsui Global Investment | Series A |
| Lux Capital | Series A |
| General Catalyst | Series A |
| Amplify Partners | Series A |
| Fifty Years | Seed |
| Recode Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 72% MoM, reaching 3.7K.
- May 27, 2026
$20M round led by Amplify Partners.
For institutional investors. Book with your work email.
Waypoint Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Waypoint Bio's valuation, stock price, and market status.
Is Waypoint Bio a public or private company?
Waypoint Bio is a private company.
What is the current stock price of Waypoint Bio?
Waypoint Bio is a private company, so its shares have no public market price. Caplight tracks Waypoint Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Waypoint Bio worth (valuation)?
Valuation information for Waypoint Bio is not publicly available.
Can I buy Waypoint Bio stock?
Waypoint Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Waypoint Bio's last funding round?
Waypoint Bio's most recent funding round was Series A on May 27, 2026.
Who are the main investors in Waypoint Bio?
Key investors in Waypoint Bio include Amplify Partners, Hummingbird Ventures.
Will Waypoint Bio IPO soon?
No public IPO plans have been announced for Waypoint Bio.
How can I track Waypoint Bio secondary market activity?
Caplight tracks bids, offers, and trades in Waypoint Bio's shares on secondary markets.